World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN57157825
Date of registration: 28/02/2001
Prospective Registration: No
Primary sponsor: Medical Research Council (MRC) (UK)
Public title: International Collaborative Ovarian Neoplasm studies (3): a trial of paclitaxel with carboplatin in the first-line treatment of ovarian cancer
Scientific title:
Date of first enrolment: 27/03/1995
Target sample size: 2000
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN57157825
Study type:  Interventional
Study design:  Randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name: Claire    Amos
Address:  MRC Clinical Trials Unit 222 Euston Road NW1 2DA London United Kingdom
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Chemotherapy indicated
2. No previous chemotherapy or radiotherapy
3. No contraindication to chemotherapy

Exclusion criteria: Does not meet inclusion criteria

Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Cancer
Cancer
Ovarian cancer
Intervention(s)
1. One group receives paclitaxel in combination with carboplatin
2. The other group receives a control treatment of either single-agent carboplatin or CAP (cyclophosphamide, doxorubicin and cisplatin)
Primary Outcome(s)
Survival time - time to progression, quality of life, health economics
Secondary Outcome(s)
Not provided at time of registration
Secondary ID(s)
ICON3
Source(s) of Monetary Support
Medical Research Council (MRC) (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history